Meeting
2018 ASCO Quality Care Symposium
Evaluation of the impact of a multidisciplinary intervention to increase pneumococcal vaccination rates in patients with advanced lung cancer.
Authors
Leila Rostamnjad
Massachusetts General Hospital, Boston, MA
Leila Rostamnjad, Kelly Goodwin, Jennifer Temel, Pamela Connolly, Julie Zydel, Gayle C. Blouin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Big Data Studies; Projects Relating to Equity, Value, and Policy
Track
Projects Relating to Equity, Value and Policy,Big Data Studies
Sub Track
Guideline Concordant Care Initiatives
Citation
J Clin Oncol 36, 2018 (suppl 30; abstr 61)
DOI
10.1200/JCO.2018.36.30_suppl.61
Abstract #
61
Poster Bd #
G2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
V CAN intervention: Quality improvement initiative to increase and sustain vaccination rates among adult patients with cancer.
First Author: Ji Lin
Poster
2021 ASCO Annual Meeting
Personalized DNA neoantigen vaccine in combination with plasmid IL-12 and pembrolizumab for the treatment of patients with advanced hepatocellular carcinoma.
First Author: Mark Yarchoan
Poster
2021 ASCO Annual Meeting
Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, combined with PD-1 inhibition in advanced solid tumors.
First Author: Maura L. Gillison
Poster
2021 ASCO Annual Meeting
A phase 1 open label trial of intravenous administration of MVA-BN-Brachyury vaccine in patients with advanced cancer.
First Author: Peter Joseph DeMaria